Evidence map›Paper›PMID 36829927›Full record

ReviewAntioxidants (Basel, Switzerland)2023

The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer.

Tomislav Pejčić, Milica Zeković, Uroš Bumbaširević, Milica Kalaba, Irena Vovk, Maja Bensa, Lazar Popović, Živoslav Tešić

Abstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tomislav PejčićFaculty of Medicine, University of Belgrade, dr Subotića 8, 11000 Belgrade, Serbia.ORCID 0000-0002-8306-8080
Milica ZekovićCentre of Research Excellence in Nutrition and Metabolism, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, Tadeusa Koscuska 1, 11000 Belgrade, Serbia.ORCID 0000-0003-2597-3426
Uroš BumbaširevićFaculty of Medicine, University of Belgrade, dr Subotića 8, 11000 Belgrade, Serbia.ORCID 0000-0003-0367-2745
Milica KalabaInstitute of General and Physical Chemistry, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0003-0989-7398
Irena VovkLaboratory for Food Chemistry, National Institute of Chemistry, Hajdrihova 19, 1000 Ljubljana, Slovenia.ORCID 0000-0002-4738-2849
Maja BensaFaculty of Health Sciences, University of Ljubljana, Zdravstvena pot 5, 1000 Ljubljana, Slovenia.ORCID 0000-0002-0563-8615
Lazar PopovićDepartment of Medical Oncology, Oncology Institute of Vojvodina, Put Doktora Goldmana 4, 21204 Sremska Kamenica, Serbia.ORCID 0000-0002-3278-6875
Živoslav TešićFaculty of Chemistry, University of Belgrade, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0002-5162-3123

Funding

Ministry of Education, Science and Technological Development of the Republic of Serbia Agreement on Realization and Financing of Scientific Research work of NIO for 2022, No.451-03-68/2022-14/200015Ministry of Education, Science and Technological Development of the Republic of Serbia Contract No.: 451-03-68/2022-14/200051Ministry of Education, Science and Technological Development of the Republic of Serbia Contract No. 451-03-68/2022-14/200168Slovenian Research Agency research program P1-0005 "Functional food and food supplements"
6 · The paper itself

Abstract

This narrative review summarizes epidemiological studies on breast cancer and prostate cancer with an overview of their global incidence distribution to investigate the relationship between these diseases and diet. The biological properties, mechanisms of action, and available data supporting the potential role of isoflavones in the prevention of breast cancer and prostate cancer are discussed. Studies evaluating the effects of isoflavones in tissue cultures of normal and malignant breast and prostate cells, as well as the current body of research regarding the effects of isoflavones attained through multiple modifications of cellular molecular signaling pathways and control of oxidative stress, are summarized. Furthermore, this review compiles literature sources reporting on the following: (1) levels of estrogen in breast and prostate tissue; (2) levels of isoflavones in the normal and malignant tissue of these organs in European and Asian populations; (3) average concentrations of isoflavones in the secretion of these organs (milk and semen). Finally, particular emphasis is placed on studies investigating the effect of isoflavones on tissues via estrogen receptors (ER).

Indexed as

breast cancerisoflavonesprostate cancer

Identifiers

PMID36829927
PMCPMC9952119

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.